LLMpediaThe first transparent, open encyclopedia generated by LLMs

GlaxoSmithKline

Generated by Llama 3.3-70B
⚠Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: United Kingdom Hop 3
Expansion Funnel Raw 77 → Dedup 39 → NER 29 → Enqueued 26
1. Extracted77
2. After dedup39 (None)
3. After NER29 (None)
Rejected: 10 (not NE: 10)
4. Enqueued26 (None)
Similarity rejected: 3
GlaxoSmithKline
GlaxoSmithKline
Ian Wilson · CC BY 2.0 · source
NameGlaxoSmithKline
Founded2000
FounderJoseph Nathan, Henry Wellcome, Silas Burroughs
LocationBrentford, London, United Kingdom

GlaxoSmithKline is a multinational pharmaceutical company that was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. The company has a rich history, with its roots dating back to the 19th century, when Joseph Nathan founded Glaxo in New Zealand, and Henry Wellcome and Silas Burroughs founded Burroughs Wellcome in London. The company's formation was a result of the merger of two pharmaceutical giants, Glaxo Wellcome and SmithKline Beecham, which were themselves the result of previous mergers, including the merger of Glaxo and Wellcome in 1995, and the merger of SmithKline Beckman and Beecham Group in 1989. The company's headquarters are located in Brentford, London, United Kingdom, and it is listed on the London Stock Exchange and the New York Stock Exchange.

● History

The history of GlaxoSmithKline dates back to the 19th century, when Joseph Nathan founded Glaxo in New Zealand in 1873, and Henry Wellcome and Silas Burroughs founded Burroughs Wellcome in London in 1880. The company's early history was marked by the development of innovative products, including vaccines and antibiotics, such as penicillin, which was discovered by Alexander Fleming in 1928. In the 20th century, the company underwent significant changes, including the merger of Glaxo and Wellcome in 1995, and the merger of SmithKline Beckman and Beecham Group in 1989. The company's merger with SmithKline Beecham in 2000 created one of the largest pharmaceutical companies in the world, with a portfolio of products that included Zantac, Imitrex, and Paxil. The company has also made significant acquisitions, including the acquisition of Block Drug in 2001, and the acquisition of Stiefel Laboratories in 2009.

● Products

GlaxoSmithKline has a diverse portfolio of products, including vaccines, antibiotics, and medicines for the treatment of various diseases, such as cancer, diabetes, and respiratory diseases. The company's products include Zantac, Imitrex, and Paxil, as well as Avodart, Lovaza, and Advair. The company has also developed innovative products, such as Cervarix, a human papillomavirus vaccine, and MenHibrix, a meningitis vaccine. The company's products are marketed in over 100 countries, including the United States, United Kingdom, Canada, Australia, and Japan. The company has also partnered with other companies, such as Pfizer, Merck & Co., and AstraZeneca, to develop and market new products.

● Research and Development

GlaxoSmithKline has a significant research and development program, with a focus on the development of innovative products for the treatment of various diseases. The company's research and development efforts are focused on several key areas, including oncology, infectious diseases, and respiratory diseases. The company has also established partnerships with other companies, such as University of California, San Francisco, Harvard University, and Massachusetts Institute of Technology, to develop new products and technologies. The company's research and development program has led to the development of several innovative products, including Tafinlar, a melanoma treatment, and Breo Ellipta, a chronic obstructive pulmonary disease treatment. The company has also invested in several research initiatives, including the GlaxoSmithKline Foundation, which supports research and development in developing countries.

● Controversies

GlaxoSmithKline has been involved in several controversies over the years, including the Avandia controversy, which involved the company's diabetes medication, and the Paxil controversy, which involved the company's antidepressant medication. The company has also faced criticism for its marketing practices, including the use of ghostwriting and off-label marketing. The company has also been involved in several lawsuits, including a lawsuit with the US Department of Justice over the company's marketing practices. The company has also faced criticism for its role in the opioid epidemic, and has been sued by several states, including California, New York, and Texas. The company has also been criticized for its pricing practices, including the high cost of its HIV medications.

● Corporate Affairs

GlaxoSmithKline is a multinational company with operations in over 100 countries. The company's headquarters are located in Brentford, London, United Kingdom, and it is listed on the London Stock Exchange and the New York Stock Exchange. The company is led by a board of directors, which includes Emma Walmsley, the company's chief executive officer. The company has also established several subsidiaries, including GlaxoSmithKline Pharmaceuticals, GlaxoSmithKline Consumer Healthcare, and GlaxoSmithKline Vaccines. The company has also partnered with several other companies, including Novartis, Eli Lilly and Company, and Sanofi, to develop and market new products. The company has also invested in several initiatives, including the GlaxoSmithKline Foundation, which supports research and development in developing countries. The company has also been recognized for its corporate social responsibility initiatives, including its diversity and inclusion programs and its sustainability initiatives. Category:Pharmaceutical companies

● Some section boundaries were detected using heuristics. Certain LLMs occasionally produce headings without standard wikitext closing markers, which are resolved automatically.